Abstract:OBJECTIVETo study mRNA expression of VEGF-(A, C, D) genes in breast carcinoma and its effect on prognosis.METHODSThe mRNA expression of VEGF-(A, C, D) genes in 61 cases of primary breast carcinoma and 29 cases of benign mammary lesions was detected by TaqMan real-time reverse transcription-polymerase chain reaction (real-time RT-PCR) technology. The correlation between mRNA expression and various clinicopathologic parameters and survival data was analyzed.RESULTSThe level of mRNA expression of VEGF-(A, C) genes was significantly higher in primary breast carcinomas (2.79 +/- 1.31 and 3.33 +/- 0.88 respectively) than in benign mammary lesions (1.59 +/- 1.35 and 2.76 +/- 0.55 respectively, P = 0.000 and 0.002 respectively). The percentage of VEGF-D mRNA expression was 73.77% in breast carcinomas, as compared to 51.72% in benign mammary lesions (P = 0.038). However, there was no statistically significant difference in the mRNA expression levels of VEGF-D gene between primary breast carcinomas and benign mammary lesions (P = 0.683). On the other hand, the ratio of VEGF-D mRNA expression to VEGF-C mRNA expression was lower in lymph node-positive than in lymph node-negative cases. This also correlated with the occurrence of nodal metastasis by uni- and multivariate analysis (P(uni) = 0.046 and P(mult) = 0.062). High mRNA expression of VEGF-(A, C) genes was associated with poor disease-free survival (P = 0.030 and 0.044 respectively).CONCLUSIONSThe expression of VEGF-(A, C, D) genes may play a role in the disease progression of breast carcinoma. The ratio of VEGF-D mRNA expression to VEGF-C mRNA expression correlates with the occurrence of lymph node metastasis in breast carcinoma. The mRNA expression of VEGF-(A, C) genes may serve as a useful prognostic indicator in breast cancer.

Expression of VEGF and its significance in breast cancer

Relationship Between the VEGF and Pathological Factor As Well As Prognostic Significance in Breast Cancer

The Expression and Clinical Significance of Vascular Endothelial Growth Factor-C in Gastric Cancer Tissues

Expressions of Survivin and VEGF in Benign and Malignant Tumors of Breast and Their Significance

Prognostic significance of vascular endothelial growth factor immunohistochemical expression in gastric cancer: a meta-analysis

Relationship Between the Expression of Vascular Endothelial Growth Factor and the Prognosis of Primary Lung Cancer Patients

Expression of Vascular Endothelial Growth Factor (VEGF) in Breast

The Expression of COX-2 and VEGF in Breast Cancer and Their Clinical Significance to Prognsis

Survivin and VEGF Expressions in Breast Cancer and their Relations

Expression of P16 and VEGF in Breast Cancer Tissue and Their Clinical Significance

Expression of cluster of differentiation 34 and vascular endothelial growth factor in breast cancer, and their prognostic significance.

Expressions of VEGF and survivin-2B mRNA in human breast cancer and tumor adjacent tissues and its clinical significance

Expression and clinicalsignicance of VEGF-D in breast cancer: a meta-analysis

The relationship between expression of VEGF in colorectal cancer and pathological factors

Study on the expression of VEGF and its clinical significance in lung neoplasms

The Clinical Significance of Serum VEGF Level in Gastric Cancer Patients

Expression and prognostic significance of VEGF and its receptor VEGFR1 and VEGFR2 in epithelial ovarian cancer

[Study of Mrna Expression of Vascular Endothelial Growth Factor-(A, C, D) Genes and Its Effect on Prognosis of Breast Cancer].

Clinopathological Significance of Vascular Endothelial Growth Factor and Nm-23 Expression in Human Breast Cancer

Expression and Its Significance of VEGF in Human Colorectal Carcinoma

Expression and Significance of Vascular Endothelial Growth Factor in Lung Carcinoma